Our work utilizes 92 of these samples that are from wtIDH1 GBM patients (the remaining 8 were mutant IDH1 samples and excluded), and incorporates bulk RNAseq, phosphoproteomics, and single nucleus RNA sequencing (snRNAseq). The gene discussed is IDH1; the disease is glioblastoma.